Michael Cloonan's most recent trade in Sionna Therapeutics Inc. was a trade of 450,252 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sionna Therapeutics Inc. | Michael Cloonan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 450,252 | 450,252 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Michael Cloonan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) |